Belimumab deemed safe for long-term lupus treatment

June 19, 2012
Belimumab deemed safe for long-Term lupus treatment
For patients with systemic lupus erythematosus, long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & Rheumatism.

(HealthDay) -- For patients with systemic lupus erythematosus (SLE), long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & Rheumatism.

Joan T. Merrill, M.D., from the Oklahoma Medical Research Foundation in Oklahoma City, and colleagues evaluated the long-term safety profile of belimumab for with active SLE. Patients who were randomized to 1, 4, or 10 mg/kg belimumab or placebo and completed a 52-week double-blind study were eligible for a 24-week extension (345 patients). Placebo patients were switched to 10 mg/kg belimumab and belimumab patients continued with their dose or were switched to 10 mg/kg. Two hundred ninety-six participants who achieved a satisfactory response were allowed to continue in the long-term evaluation of monthly 10 mg/kg belimumab.

The researchers found that, during four-year belimumab exposure, the incidence rates of adverse events (AEs), severe/serious AEs, infusion reactions, infections, malignancies, grades 3/4 laboratory abnormalities, and AE-related discontinuations remained stable or decreased. Arthralgia, upper respiratory tract infection, headache, fatigue, and nausea were the most common AEs. Only one serious infusion reaction occurred during the four-year follow-up. No specific infection type dominated the AEs and serious infection rates decreased from 5.9 to 3.4/100 patient-years.

"Belimumab added to standard therapy was generally well tolerated over four-year treatment for SLE, suggesting that belimumab can be administered long term with an acceptable safety profile," the authors write.

Several authors disclosed financial ties to Human Genome Sciences Inc. and GlaxoSmithKline, both of which funded the study and manufacture belimumab.

Explore further: Chemo combination promising for multiple myeloma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Chemo combination promising for multiple myeloma

May 2, 2012
(HealthDay) -- For patients with relapsed or refractory multiple myeloma, combination treatment with elotuzumab, lenalidomide, and low-dose dexamethasone is generally well tolerated, with encouraging response rates, according ...

Sumatriptan/Naproxen helpful in treating teens' migraines

May 15, 2012
(HealthDay) -- Treatment with sumatriptan and naproxen sodium (suma/nap) is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics.

Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients

October 27, 2011
Atorvastatin therapy was found to be ineffective in reducing atherosclerosis progression in children and adolescents with systemic lupus erythematosus (SLE). Results of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus ...

Etanercept shows promise for treating dermatomyositis

June 17, 2011
A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy. These results are encouraging, ...

Recommended for you

US arthritis prevalence is much higher than current estimates

November 27, 2017
New research indicates that the prevalence of arthritis in the United States has been substantially underestimated, especially among adults

Maintaining sufficient vitamin D levels may help to prevent rheumatoid arthritis

November 20, 2017
Maintaining sufficient vitamin D levels may help to prevent the onset of inflammatory diseases like rheumatoid arthritis, research led by the University of Birmingham has discovered.

Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy

November 16, 2017
In the quest for a new and more effective treatment for rheumatoid arthritis, researchers from the Keck School of Medicine of USC looked to a primate that mostly roams the land in Asia, the Middle East and Africa. It was ...

Study lists foods for fighting rheumatoid arthritis symptoms and progression

November 8, 2017
A list of food items with proven beneficial effects on the progression and symptoms of rheumatoid arthritis is provided in a new study published today in Frontiers in Nutrition. The authors suggest incorporating these foods ...

Prototype equipment can detect rheumatoid arthritis

September 28, 2017
According to a first clinical study published in the scientific journal Photoacoustics, the University of Twente and various European partners have designed a device that shows the difference between healthy fingers and arthritic ...

Improving the recognition of anxiety and depression in rheumatoid arthritis

August 28, 2017
A study conducted by Keele University shows that patients with rheumatoid arthritis who are also suffering with anxiety or depression may avoid talking to their GP about their mental health symptoms.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.